We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

Early time-restricted eating could help people lose weight and improve blood pressure, according to new research from the ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

Shingles vaccine may slow dementia A shot at preventing dementia. A shingles vaccine, meant to fight a virus, also protects ...

People in their 60s who used hearing aids to treat hearing loss had less risk of dementia over time. Most studies of hearing aids and dementia have focused on adults over age 70. This analysis may be ...

There’s rarely good news about Alzheimer’s disease, but a failed study may open the door to more research about vascular dementia. Novo Nordisk NVO announced Monday that its oral GLP-1 called Rybelsus ...

Even though Novo Nordisk's GLP-1 failed in Alzheimer's trial, some researchers are cautiously optimistic that obesity and diabetes drugs may have benefits for people with one of the most common forms ...

Hearing loss was associated with smaller brain volumes and a 71% higher risk for dementia, particularly in individuals carrying the apolipoprotein E (APOE) epsilon 4 (APOEε4) allele, new research ...

Dementia is a serious global health problem. Right now, about 50 million people have dementia, and that number is expected to rise to over 150 million by the year 2050. At the same time, obesity is ...

Objectives: There is evidence that periodontitis can enhance the progression of Alzheimer's disease (AD). The biomarkers beta-amyloid (40 and 42), total tau, and phospho-tau181 (pTau181) in ...